HUP0500103A2 - Oxigén-és/vagy kénatomot tartalmazó tetraciklusos vegyületek, eljárás egyes képviselőik előállítására, alkalmazásuk és a vegyületeket tartalmazó gyógyászati készítmények - Google Patents
Oxigén-és/vagy kénatomot tartalmazó tetraciklusos vegyületek, eljárás egyes képviselőik előállítására, alkalmazásuk és a vegyületeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0500103A2 HUP0500103A2 HU0500103A HUP0500103A HUP0500103A2 HU P0500103 A2 HUP0500103 A2 HU P0500103A2 HU 0500103 A HU0500103 A HU 0500103A HU P0500103 A HUP0500103 A HU P0500103A HU P0500103 A2 HUP0500103 A2 HU P0500103A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- crarb
- things
- compounds
- atom
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 229910052760 oxygen Inorganic materials 0.000 title abstract 2
- 229910052717 sulfur Inorganic materials 0.000 title abstract 2
- 125000004434 sulfur atom Chemical group 0.000 title abstract 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 title 1
- 239000001301 oxygen Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- -1 hydroxyl- Chemical group 0.000 abstract 2
- 208000033830 Hot Flashes Diseases 0.000 abstract 1
- 206010060800 Hot flush Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 206010047791 Vulvovaginal dryness Diseases 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229940124558 contraceptive agent Drugs 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 102000015694 estrogen receptors Human genes 0.000 abstract 1
- 108010038795 estrogen receptors Proteins 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 206010020718 hyperplasia Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Abstract
A találmány tárgyát képezik az (I) általános képletű vegyületek ahol aképletben - - -jelentése egyszeres vagy kétszeres kötés; X jelentéseO- vagy S-atom és Y jelentése - feltételekkel - CRARB-, CRARB(CRARB)1-2-csoport; Z jelentése O- vagy S-atom; R1 jelentése - egyebek mellett- hidrogénatom, alkil-, alkenil-, cikloalkil-, arilcsoport, R2jelentése - egyebek mellett - hidroxil-, alkil-, alkenil-,cikloalkil-, arilcsoport; alternatív megoldásként - feltételekkel - R1és R2 együtt azzal a szénatommal, amelyhez kapcsolódnak, C(O)-csoportot képez; n jelentése 0-4 értékű egész szám; minden egyes R3jelentése - egyebek mellett - egymástól függetlenül a következők közülválasztott csoport: halogénatom, hidroxil-, amino-, alkil-amino-csoport, m jelentése 0-4 értékű egész szám; minden egyes R4 jelentése- feltételekkel, egyebek mellett - egymástól függetlenül halogénatom,hidroxií-, amino-, alkil-amino-, dialkil-amino-, nitrocsoport; RA, RBjelentései a leírásban megadottak; vagy a vegyületek gyógyászatilagelfogadható sói. A találmány tárgya az (I) általános képletűvegyületek alkalmazása az ösztrogén receptor által közvetítettbetegségek (pl. hőhullámok, vaginakiszáradás, osteoporozis,hiperlipidémia, hormonérzékeny rákok, hiperplázia) kezelésére és/vagymegelőzésére alkalmas gyógyszerkészítmények előállítására is. Továbbáalkalmazhatók fogamzásgátló szerekként önmagukban vagy kombinációkban.A találmány tárgya még egyes (I) általános képletű vegyületekelőállítási eljárásai és az új köztitermékek. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34195701P | 2001-12-19 | 2001-12-19 | |
| PCT/US2002/038486 WO2003053977A1 (en) | 2001-12-19 | 2002-12-02 | Tetracyclic heterocompounds as estrogen receptor modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0500103A2 true HUP0500103A2 (hu) | 2005-05-30 |
| HUP0500103A3 HUP0500103A3 (en) | 2009-01-28 |
Family
ID=23339719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0500103A HUP0500103A3 (en) | 2001-12-19 | 2002-12-02 | Tetracyclic compounds containing oxygen and/or sulfur atom, process for the preparation of some of them, their use and pharmaceutical compositions containing them |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1467998B1 (hu) |
| JP (1) | JP2005513133A (hu) |
| CN (1) | CN1620457A (hu) |
| AR (1) | AR038661A1 (hu) |
| AT (1) | ATE321764T1 (hu) |
| AU (1) | AU2002362041A1 (hu) |
| BR (1) | BR0215152A (hu) |
| CA (1) | CA2471107A1 (hu) |
| CY (1) | CY1105361T1 (hu) |
| DE (1) | DE60210333T2 (hu) |
| DK (1) | DK1467998T3 (hu) |
| ES (1) | ES2264737T3 (hu) |
| HK (1) | HK1068875A1 (hu) |
| HU (1) | HUP0500103A3 (hu) |
| IL (1) | IL162295A0 (hu) |
| MX (1) | MXPA04006034A (hu) |
| NZ (1) | NZ533281A (hu) |
| PL (1) | PL371045A1 (hu) |
| PT (1) | PT1467998E (hu) |
| RU (1) | RU2305099C2 (hu) |
| WO (1) | WO2003053977A1 (hu) |
| ZA (1) | ZA200405653B (hu) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7329654B2 (en) * | 2001-12-19 | 2008-02-12 | Janssen Pharmaceutica N.V. | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| US7105679B2 (en) | 2001-12-19 | 2006-09-12 | Kanojia Ramesh M | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| WO2005073244A1 (en) * | 2004-01-22 | 2005-08-11 | Eli Lilly And Company | Selective estrogen receptor modulators |
| AU2005300030B2 (en) * | 2004-09-20 | 2012-01-12 | Janssen Pharmaceutica N.V. | Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| CN101242817B (zh) | 2005-06-15 | 2016-08-31 | 菲布罗根公司 | HIF1α调节剂在治疗癌症中的用途 |
| DE102006024032A1 (de) * | 2006-05-23 | 2007-11-29 | Voith Patent Gmbh | Anordnung zur Bandregelung |
| PL2580210T3 (pl) * | 2010-06-10 | 2017-09-29 | Seragon Pharmaceuticals, Inc. | Modulatory receptora estrogenowego i ich zastosowania |
| BR112014014124A2 (pt) * | 2011-12-14 | 2017-08-22 | Seragon Pharmaceutical Inc | Moduladores do receptor de estrogênio fluorados e usos dos mesmos |
| CN113135884B (zh) * | 2020-01-20 | 2023-03-10 | 西华大学 | 一种异色烯类化合物及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL124481C (hu) * | 1964-11-04 | |||
| CA2214196A1 (en) * | 1996-09-26 | 1998-03-26 | Eli Lilly And Company | Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods |
| ES2185054T3 (es) * | 1996-12-13 | 2003-04-16 | Chugai Pharmaceutical Co Ltd | Derivados de benzopirano. |
-
2002
- 2002-12-02 MX MXPA04006034A patent/MXPA04006034A/es active IP Right Grant
- 2002-12-02 HU HU0500103A patent/HUP0500103A3/hu unknown
- 2002-12-02 WO PCT/US2002/038486 patent/WO2003053977A1/en active IP Right Grant
- 2002-12-02 RU RU2004118606/04A patent/RU2305099C2/ru not_active IP Right Cessation
- 2002-12-02 CN CNA028281446A patent/CN1620457A/zh active Pending
- 2002-12-02 BR BR0215152-9A patent/BR0215152A/pt not_active IP Right Cessation
- 2002-12-02 ES ES02797167T patent/ES2264737T3/es not_active Expired - Lifetime
- 2002-12-02 PT PT02797167T patent/PT1467998E/pt unknown
- 2002-12-02 NZ NZ533281A patent/NZ533281A/en unknown
- 2002-12-02 AT AT02797167T patent/ATE321764T1/de not_active IP Right Cessation
- 2002-12-02 DK DK02797167T patent/DK1467998T3/da active
- 2002-12-02 CA CA002471107A patent/CA2471107A1/en not_active Abandoned
- 2002-12-02 PL PL02371045A patent/PL371045A1/xx not_active Application Discontinuation
- 2002-12-02 AU AU2002362041A patent/AU2002362041A1/en not_active Abandoned
- 2002-12-02 EP EP02797167A patent/EP1467998B1/en not_active Expired - Lifetime
- 2002-12-02 DE DE60210333T patent/DE60210333T2/de not_active Expired - Fee Related
- 2002-12-02 JP JP2003554693A patent/JP2005513133A/ja not_active Withdrawn
- 2002-12-02 IL IL16229502A patent/IL162295A0/xx unknown
- 2002-12-18 AR ARP020104957A patent/AR038661A1/es unknown
-
2004
- 2004-07-15 ZA ZA200405653A patent/ZA200405653B/xx unknown
-
2005
- 2005-02-15 HK HK05101213A patent/HK1068875A1/xx not_active IP Right Cessation
-
2006
- 2006-06-08 CY CY20061100768T patent/CY1105361T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005513133A (ja) | 2005-05-12 |
| RU2004118606A (ru) | 2006-01-10 |
| EP1467998A1 (en) | 2004-10-20 |
| ATE321764T1 (de) | 2006-04-15 |
| WO2003053977A1 (en) | 2003-07-03 |
| BR0215152A (pt) | 2004-10-19 |
| CY1105361T1 (el) | 2010-03-03 |
| MXPA04006034A (es) | 2005-03-31 |
| AU2002362041A1 (en) | 2003-07-09 |
| CN1620457A (zh) | 2005-05-25 |
| IL162295A0 (en) | 2005-11-20 |
| ZA200405653B (en) | 2006-06-28 |
| DE60210333T2 (de) | 2006-11-30 |
| PT1467998E (pt) | 2006-08-31 |
| DK1467998T3 (da) | 2006-07-31 |
| PL371045A1 (en) | 2005-06-13 |
| DE60210333D1 (de) | 2006-05-18 |
| CA2471107A1 (en) | 2003-07-03 |
| EP1467998B1 (en) | 2006-03-29 |
| RU2305099C2 (ru) | 2007-08-27 |
| HK1068875A1 (en) | 2005-05-06 |
| ES2264737T3 (es) | 2007-01-16 |
| HUP0500103A3 (en) | 2009-01-28 |
| NZ533281A (en) | 2007-05-31 |
| AR038661A1 (es) | 2005-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT925301E (pt) | Derivados altamente lipofilos de camptotecina | |
| PL351954A1 (en) | Indoline derivatives as progesterone antagonists | |
| NO20073257L (no) | 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same | |
| EP1534271B1 (en) | Antitumor compound and therapeutic uses thereof | |
| HUP0500103A2 (hu) | Oxigén-és/vagy kénatomot tartalmazó tetraciklusos vegyületek, eljárás egyes képviselőik előállítására, alkalmazásuk és a vegyületeket tartalmazó gyógyászati készítmények | |
| ATE320426T1 (de) | Harnstoffderivate und ihre verwendung | |
| DK1124842T3 (da) | Betulinsyrederivater anvendelige til behandling af neuroektodermale tumorer | |
| MY139446A (en) | Novel quinoline derivatives | |
| JP2013540129A (ja) | がん治療で使用するためのゲムシタビンのアミド亜リン酸エステル誘導体 | |
| JPS61282368A (ja) | 抗がん性キナゾリン誘導体 | |
| TW200736189A (en) | Indene derivatives, their preparation and use as medicaments | |
| BR0215151A (pt) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
| KR970701719A (ko) | 헤테로고리화합물과 그것의 제법 및 사용(heterocyclic compounds, their preparation and use) | |
| IL156967A0 (en) | Camptothecin derivatives | |
| HUP0102512A2 (hu) | Áthidalt indeno-pirrolo-karbazol-származékok, eljárás az előállításukra, a vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| MXPA04003087A (es) | Derivados de cromano como ligados de 5-hidroxitriptamina-6. | |
| PL1727817T3 (pl) | Pochodne azabicyklooktan-3-onu i ich zastosowanie | |
| Akinboye et al. | Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines | |
| NZ516506A (en) | Interleukin-5 inhibiting 6-azauracil derivatives | |
| PT912185E (pt) | Novas formulacoes farmaceuticas contendo derivados de ester nitrato de esteroides proveitosos como farmacos anti-inflamatorios | |
| Demkowicz et al. | Synthesis of bicoumarin thiophosphate derivatives as steroid sulfatase inhibitors | |
| NZ545580A (en) | Aminoquinoline derivatives and their use as adenosine A3 ligands | |
| HUP0401350A2 (hu) | Terápiás hatású új imidazopiridin-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0100102A2 (hu) | Fenil-amino-alkilkarbonsav-származékok és fenil-amino-alkilkarbonsav-származékokat tartalmazó gyógyszerészeti készítmények | |
| HUP0001845A2 (hu) | Benzotiofénszármazékok alkalmazása emlőrák megelőzésére szolgáló gyógyszerkészítmények előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |